Desensitization and Recovery of Prostaglandin-Stimulated Adenylate Cyclase Activity in a Murine Virus-Induced T Lymphoma Cell Line BL/VL₃

References

• Garaci E., Favalli C., Rinaldi‐Garaci C. Thymic hormones and lymphokines, A. L. Goldstein. Plenum Press, New York, NY 1984; 413–420
   Google Scholar
• Kennedy M. S., Stobo J. D., Goldyne M. E. In vitro synthesis of prostaglandins and related lipids by populations of human peripheral blood mononuclear cells. Prostaglandins 1980; 20: 135–145
   PubMedGoogle Scholar
• Bankhurst A. D., Hastain E., Goodwin J. S., Peake G. T. The nature of the prostaglandin‐producing mononuclear cell in human peripheral blood. J. Lab. Clin. Med. 1981; 97: 179–186
   PubMedGoogle Scholar
• Aussel C., Mary D., Fehlmann M. Prostaglandin synthesis in human T cells: its partial inhibition by lectins and anti‐CD3 antibodies as a possible step in T cell activation. J. Immunol. 1987; 138: 3094–3099
   PubMedGoogle Scholar
• Declève A., Lieberman M., Ihle J. N., Rosenthal P. N., Lung M. L., Kaplan H. S. Physicochemical, biological and serological properties of a leukemogenic virus isolated from cultured RadLV‐induced lymphomas of C57BL/Ka mice. Virology 1978; 90: 23–35
   PubMed Web of Science ®Google Scholar
• Lieberman M., Declève A., Ricciardi‐Castagnoli P., Boniver J., Finn O. J., Kaplan H. S. Establishment, characterization and virus expression of cell lines derived from radiation and virus‐induced lymphomas of C57 BL/Ka mice. Int. J. Cancer 1979; 24: 168–177
   PubMed Web of Science ®Google Scholar
• Robberecht P., Waelbroeck M., Abello J., Damien C., De Neef P., Tastenoy M., Hooghe R., Christophe J. Variable expression of VIP and β‐adrenergic receptors coupled to adenylate cyclase in murine T cell lymphomas of immature, helper, and cytotoxic types. Immunobiology
   Google Scholar
• Abello J., Damien C., De Neef P., Tastenoy M., Hooghe R., Robberecht P., Christophe J. Properties of vasoactive‐intestinal‐peptide receptors and β‐adrenoceptors in the murine radiation leukemia virus‐induced lymphoma cell line BL/VL3. Eur. J. Biochem. 1989; 183: 263–267
   PubMedGoogle Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal. Biochem. 1974; 58: 541–548
   PubMed Web of Science ®Google Scholar
• Vandermeers A., Vandermeers‐Piret M. C., Robberecht P., Waelbroeck M., Dehaye J. P., Winand J., Christophe J. Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP‐ and secretin‐like properties (Helodermin) from Gila monster venom. FEBS Lett. 1984; 166: 273–276
   PubMedGoogle Scholar
• Abello J., Damien C., Robberecht P., Hooghe R., Vandermeers A., Vandermeers‐Piret M. C., Christophe J. Homologous and heterologous regulation of the helodermin‐vasoactive intestinal peptide response in the murine radiation leukemia virus‐induced lymphoma cell line BL/VL3. Eur. J. Biochem. 1989; 183: 269–274
   PubMedGoogle Scholar
• Sibley D. R., Daniel K., Strader C. D., Lefkowitz R. J. Phosphorylation of the β‐adrenergic receptor in intact cells: Relationship to heterologous and homologous mechanisms of adenylate cyclase desensitization. Arch. Biochem. Biophys. 1987; 258: 24–32
   PubMedGoogle Scholar
• Hsia J. A., Hewlett E. L., Moss J. Heterologous desensitization of adenylate cyclase with prostaglandin E1 alters sensitivity to inhibitory as well as stimulatory agonists. J. Biol. Chem. 1985; 260: 4922–4926
   PubMedGoogle Scholar
• Clark R. B., Kunkel M. W., Friedman J., Goka T. J., Johnson J. A. Activation of cAMP‐dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild‐type lymphoma cells. Proc. Natl. Acad. Sci. USA 1988; 85: 1442–1446
   PubMedGoogle Scholar
• Garrity M. J., Andreasen T. J., Storm D. R., Robertson R. P. Prostaglandin E‐induced heterologous desensitization of hepatic adenylate cyclase. J. Biol. Chem. 1983; 258: 8692–8697
   PubMedGoogle Scholar
• Sibley D. R., Strasser R. H., Caron M. G., Lefkowitz R. J. Homologous desensitization of adenylate cyclase is associated with phosphorylation of the β‐adrenergic receptor. J. Biol. Chem. 1985; 260: 3883–3886
   PubMed Web of Science ®Google Scholar
• Strasser R. H., Benovic J. L., Caron M. G., Lefkowitz R. J. β‐Agonist‐ and prostaglandin E1‐induced translocation of the β‐adrenergic receptor kinase: Evidence that the kinase may act on multiple adenylate cyclase‐coupled receptors. Proc. Natl. Acad. Sci. USA 1986; 83: 6362–6366
   PubMed Web of Science ®Google Scholar
• Damien C., Robberecht P., Abello J., Hooghe R., Christophe J. VIP‐helodermin receptors in the murine virus‐induced T lymphoma cell line BL/VL3 recover less rapidly than β‐adrenoceptors after down regulation. J. Receptor Res.
   Google Scholar
• Hughes R. J., Insel P. A. Agonist‐mediated regulation of α1 and β2‐adrenergic receptor metabolism in a muscle cell line. BC 3H‐1. Mol. Pharmacol. 1986; 29: 521–530
   PubMedGoogle Scholar
• Neve K. A., Molinoff P. B. Turnover of β1‐ and β2‐adrenergic receptors after down‐regulation or irreversible blockade. Mol. Pharmacol. 1986; 30: 104–111
   PubMed Web of Science ®Google Scholar
• Mahan L. C., Insel P. A. Expression of β‐adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle. Mol. Pharmacol. 1986; 29: 7–15
   PubMed Web of Science ®Google Scholar
• Waldo G. L., Doss R. C., Perkins J. P., Harden T. K. Use of a density shift method to assess beta‐adrenergic receptor synthesis during recovery from catecholamine‐induced down‐regulation in human astrocytoma cells. Mol. Pharmacol. 1984; 26: 424–429
   PubMedGoogle Scholar